Ionophore antibiotics are promising compounds with potent anticancer and anti-cancer stem cell (anti-CSC) activity. However, resistance mediated by drug transporters potentially confines their use to CSC populations that do not exhibit appreciable drug efflux capacity. Further research is required to delineate which CSC subsets are likely to be susceptible to ionophore antibiotic cytotoxicity.
No takes yet. Share an insight, caveat, or question.
Boesch et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: